Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03011736 · ClinicalTrials.gov registry record · NA
Omission of Intact Parathyroid Hormone Testing During Surgery in Treating Patients With Primary Hyperparathyroidism
A NA study, sponsored by Roswell Park Cancer Institute.
- Completed
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT03011736 is a NA study that has completed, run by Roswell Park Cancer Institute. The registered enrollment target is 6 participants.
The verdict
NCT03011736, a NA study, has completed, sponsored by Roswell Park Cancer Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
This clinical trial studies the omission of intact parathyroid hormone testing during surgery in treating patients with primary hyperparathyroidism. Omission of intact parathyroid hormone testing during parathyroid gland removal may help patients with primary hyperparathyroidism to decrease their time under anesthesia, and decrease the overall time and cost of surgery.
Interventions
- OTHER Laboratory Biomarker Analysis
- PROCEDURE Parathyroidectomy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2016-05-12 |
| Est. Completion | 2018-12-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03011736
The ClinicalTrials.gov registry entry for NCT03011736 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Roswell Park Cancer Institute, which has 365 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Laboratory Biomarker Analysis is the first listed.
NCT03011736 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03011736 about?
NCT03011736 is a clinical study titled "Omission of Intact Parathyroid Hormone Testing During Surgery in Treating Patients With Primary Hyperparathyroidism". This clinical trial studies the omission of intact parathyroid hormone testing during surgery in treating patients with primary hyperparathyroidism. Omission of intact parathyroid hormone testing during parathyroid gland removal may help patients with primary hyperparathyroidism to decrease their ti...
What is the current status of trial NCT03011736?
This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2016-05-12. Estimated completion is 2018-12-24.
What interventions are being tested in trial NCT03011736?
The interventions under investigation include: Laboratory Biomarker Analysis (OTHER), Parathyroidectomy (PROCEDURE).
Who is sponsoring clinical trial NCT03011736?
This trial is sponsored by Roswell Park Cancer Institute, which has 365 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.